NewsRoom Articles - Page 28 of 29

MondayJun 13, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) and the Budding Alternative Nicotine Market

The nicotine pouch market is projected to reach $21.84 billion in 2027, up from $2.33 billion in 2020, representing a CAGR of 30.7%The smokeless tobacco products sector is expected to post a CAGR of 7.2% over the forecast period (2018-2025)Lexaria, through its patented DehydraTECH technology, is tapping into this important alternative nicotine sector Its management is confident that its research and technology development investment will pay off and provide greater consumer satisfaction. In 2019, it was estimated that at least 1.1 billion people globally smoked cigarettes regularly. 780 million, representing 71% of the global smoking population, noted that they wanted to…

FridayJun 10, 2022 9:00 am

New Spike in COVID Infections, 1M+ Death Toll, Underscore Potential Value of Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Technologies

Biotech innovation company Aditxt, Inc. is a Richmond, VA based company focused on developing and commercializing technologies to monitor and reprogram the immune system with the ultimate goal of improving patient outcomes for a variety of conditions ranging from seasonal allergies to organ transplant rejectionAditxt’s first commercial product, AditxtScore(TM), helps patients obtain data relating to COVID-19 infection and vulnerabilityWhile immunization rates and the seasonal reduction of COVID infections have spurred optimism about enjoying normal public activities, a recent spike in COVID infections has led national health officials to again warn Americans to not become complacent about the pandemicHealth officials also…

FridayJun 03, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Mines Potential of Helping Medicines Do What they Do, But Better

Lexaria Bioscience is a global innovator in drug delivery platforms, developing a technology designed to improve the performance of other medicinal products by making them more rapidly and effectively usable by patients’ bodiesLexaria’s patented DehydraTECH technology has been studied in combination with a number of other products, including but not limited to, cannabidiol (“CBD”), oral nicotine, antivirals, NSAIDs, and erectile dysfunction therapiesThe company is pursuing FDA approval under the Investigational New Drug (“IND”) process to clinically test its DehydraTECH-CBD for the treatment of high blood pressureA driving focus of the company’s R&D has been to improve the speed of onset,…

TuesdayMay 31, 2022 10:30 am

Mullen Automotive Inc. (NASDAQ: MULN) Working to Alleviate Consumer Anxiety by Offering EVs with 600-Plus Mile Range

J.D. Power survey reports range was factor most cited in deciding what EV to buyMullen is making significant strides toward producing vehicles that feature some of the longest ranges available in the EV spaceRecognizing the critical role of battery and range in the success of an EV, Mullen is exploring other advanced battery technologies One of the challenges preventing enthusiastic acceptance of electric vehicles is range anxiety, fear that an electric car will run out of battery or fuel before the driver can reach their destination or a charging station. The concern is valid — a January 2022 Energy.gov study…

TuesdayMay 31, 2022 9:45 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain

Study shows that COVID-19 pandemic has affected mental health of 59% of U.S. population, intensifying already-serious issueCYBN-sponsored feasibility study indicates ketamine-induced changes in brain’s functional connectivity persisted for several days after receiving the substanceKernel Flow pivotal in developing most accurate, effective treatment regimens for patients The challenges associated with mental-health issues are rising, following the global pandemic. Already a serious problem before COVID-19, mental health has become even more pressing now, with many companies committed to offering relief to the nearly 1 billion people worldwide who deal with mental-health issues. Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed…

FridayMay 27, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities

Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technologyThe DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastesLexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applicationsThe company operates several subsidiary companies to focus on different commercial opportunities Ever since acquiring its first intellectual property (“IP”) that subsequently formed the basis of its first two patent application filings in 2014, biotechnology company Lexaria Bioscience (NASDAQ: LEXX) has grown the number of patents granted and patent applications exponentially,…

MondayMay 23, 2022 12:00 pm

Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Tie-up with Endorphina, Further Expands B2B Online Game Offering

Golden Matrix Group recently announced a tie-up with online slot-game provider, EndorphinaThe venture will see Golden Matrix Group amalgamate Endorphina’s 100 game portfolio on to their existing B2B gaming portfolioGMGI currently provide gaming platforms with access to upwards of 10,000 games drawn from over 25 gaming studios via their GMX-Ag systemGolden Matrix Group separately announced that they were in the process of further expanding their UK-focused RKingsCompetitions’ offering, an online competition provider credited with providing GMGI with over 90,000 new gamers per quarter Online gambling is disrupting the gaming industry as we know it. The online gaming industry is expected…

MondayMay 23, 2022 11:15 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Appears Well Positioned as Surging Energy Crisis Calls for Urgent Action Towards Non-Fossil-Fuel Alternatives

RNG can be key part of the solution to current energy crisis as it offers viable alternative to liquid natural gasAs so-called “drop-in fuel,” RNG doesn’t require costly changes since existing infrastructure can be used, making scaled utilization of RNG quick and affordableEverGen appears well-positioned to offer solutions that can contribute to energy security amid heightened global uncertainty Although concerns about climate change have attracted a lot of attention to the Renewable Natural Gas (“RNG”) space, it is the recently heightened geopolitical risks that could incite a new wave of interest in this non-fossil-fuel alternative as the world seeks effective…

MondayMay 23, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Unveils New Platform that Makes Energy Optimization Easy Moving Forward

Correlate Infrastructure Partners offers a complete suite of proprietary clean energy assessment solutions for the commercial real estate industry, offering facilities access to clean electrification solutionsThe company recently unveiled the Correlate Portfolio Health platform product that seeks to empower real estate owners with energy optimization and procurement capabilitiesThe platform is designed to offer recommendations that simplify complex energy analysis, procurement, and funding of deferred maintenance CIPI has unveiled the platform at a critical time as experts warn that buildings must have achieved net-zero carbon emissions by 2050 if the goals of the Paris Agreement are to be realized For the world…

MondayMay 23, 2022 9:45 am

Aditxt Inc. (NASDAQ: ADTX) Planning Nationwide Rollout of its AditxtScore(TM) Immune Monitoring Platform

Aditxt recently entered a multi-year partnership with GRS for the promotion of its proprietary AditxtScore Immune Monitoring PlatformAditxt plans to roll out the monitoring platform to medical offices, pharmacies, laboratories, and employers across the country, with promotion through nationwide television commercials AditxtScore(TM) monitors the current immune response not genetic sequencing Continuing research into COVID-19 is being done worldwide, with some researchers showing concern among the population of vaccinated individuals testing positive for the virus – including concerns about the durability of protection against highly contagious emerging strands. Researchers are still learning more about vaccinations against viruses and diseases in comparison to…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (310) 299-1717